Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Nov 30;11(1):23143.
doi: 10.1038/s41598-021-02172-8.

Clinical strategy of repeat biopsy in patients with atypical small acinar proliferation (ASAP)

Hwanik Kim #  1 , Jung Kwon Kim #  1 , Gheeyoung Choe  2 , Sung Kyu Hong  3   4
Affiliations

Clinical strategy of repeat biopsy in patients with atypical small acinar proliferation (ASAP)

Hwanik Kim et al. Sci Rep. .

Abstract

Atypical small acinar proliferation (ASAP) occurs in approximately 5% of prostate biopsies. Approximately 30-40% of patients with ASAP have biopsy detectable prostate cancer (PCa) within 5 years. Current guidelines recommend a repeat biopsy within 3-6 months after the initial diagnosis. The aim of the present study was to examine the association between ASAP and subsequent diagnosis of clinically significant PCa (csPCa). The need for immediate repeat biopsy was also evaluated. We identified 212 patients with an ASAP diagnosis on their first biopsy at our institution between February 2006 and March 2018. Of these patients, 102 (48.1%) had at least one follow-up biopsy. Clinicopathologic features including rates of subsequent PCa and csPCa were assessed. Thirty-five patients subsequently underwent radical prostatectomy (RP). Their pathologic results were reviewed. csPCa was defined as the presence of Gleason score (GS) ≥ 3 + 4 in ≥ 1 biopsy core. Adverse pathology (AP) was defined as high-grade (primary Gleason pattern ≥ 4) or non-organ-confined disease (pT3/N1) after RP. Of 102 patients, 87 (85.3%), 13 (12.7%), and 2 (2.0%) had one, two, and three follow-up biopsies, respectively. Median time from the initial ASAP diagnosis to the 2nd follow-up biopsy and the last follow-up biopsy were 21.9 months (range 1-129 months) and 27.7 months (range 1-129 months), respectively. Of these patients, 46 (45.1%) were subsequently diagnosed with PCa, including 20 (19.6%) with csPCa. Only 2 (2.0%) patients had GS ≥ 8 disease. Five (4.9%) patients had number of positive cores > 3. Of 35 patients who subsequently underwent RP, seven (20%) had AP after RP and 17 (48.6%) showed GS upgrading. Of these 17 patients, the vast majority (16/17, 94.1%) had GS upgrading from 3 + 3 to 3 + 4. 45.1% of patients with an initial diagnosis of ASAP who had repeat prostate biopsy were subsequently diagnosed with PCa and 19.6% were found to have csPCa. Our findings add further evidence that after a diagnosis of ASAP, a repeat biopsy is warranted and that the repeat biopsy should not be postponed.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Figure 1
Figure 1
Patients with subsequent biopsy results.
See this image and copyright information in PMC

References

    1. Ha Chung, B., Horie, S. & Chiong, E. The incidence, mortality, and risk factors of prostate cancer in Asian men. Prostate Int.7, 1–8. 10.1016/j.prnil.2018.11.001 (2019). - PMC - PubMed
    1. Gann PH, Fought A, Deaton R, Catalona WJ, Vonesh E. Risk factors for prostate cancer detection after a negative biopsy: A novel multivariable longitudinal approach. J. Clin. Oncol. 2010;28:1714–1720. doi: 10.1200/JCO.2008.20.3422. - DOI - PMC - PubMed
    1. Montironi R, et al. Atypical foci suspicious but not diagnostic of malignancy in prostate needle biopsies (also referred to as “atypical small acinar proliferation suspicious for but not diagnostic of malignancy”) Eur. Urol. 2006;50:666–674. doi: 10.1016/j.eururo.2006.07.048. - DOI - PubMed
    1. Koca O, Calışkan S, Oztürk M, Güneş M, Karaman MI. Significance of atypical small acinar proliferation and high-grade prostatic intraepithelial neoplasia in prostate biopsy. Korean J. Urol. 2011;52:736–740. doi: 10.4111/kju.2011.52.11.736. - DOI - PMC - PubMed
    1. Iczkowski KA. Current prostate biopsy interpretation: Criteria for cancer, atypical small acinar proliferation, high-grade prostatic intraepithelial neoplasia, and use of immunostains. Arch. Pathol. Lab Med. 2006;130:835–843. doi: 10.5858/2006-130-835-cpbicf. - DOI - PubMed